Trial intelligence / Profile preview

House dust mite sublingual film in Chinese adults with allergic rhinitis (Phase II)

CTR20260034Phase 2Active

Sponsor
Wolwo Biotech
Start
Apr 2026
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of dermatophagoides farinae in allergic rhinitis (AR), allergic conjunctivitis (AC), asthma, sponsored by Wolwo Biotech. Started Apr 2026; status: active.

02

Drugs

dermatophagoides farinae
03

Conditions

allergic rhinitis (AR)allergic conjunctivitis (AC)asthma

Beyond the preview

Go deeper on CTR20260034.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20260034.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call